This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Sep;14(8):781-3.

doi: 10.1016/j.ejpain.2010.06.017. Epub 2010 Jul 24.

Tapentadol and its two mechanisms of action: is there a new pharmacological class of centrally-acting analgesics on the horizon?

PMID: 20659810
DOI: 10.1016/j.ejpain.2010.06.017

Editorial

Tapentadol and its two mechanisms of action: is there a new pharmacological class of centrally-acting analgesics on the horizon?

Hans G Kress. Eur J Pain. 2010 Sep.

. 2010 Sep;14(8):781-3.

doi: 10.1016/j.ejpain.2010.06.017. Epub 2010 Jul 24.

Author

PMID: 20659810
DOI: 10.1016/j.ejpain.2010.06.017

No abstract available

PubMed Disclaimer

Comment on

Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain.
Schröder W, Vry JD, Tzschentke TM, Jahnel U, Christoph T. Schröder W, et al. Eur J Pain. 2010 Sep;14(8):814-21. doi: 10.1016/j.ejpain.2010.05.005. Epub 2010 Jun 11. Eur J Pain. 2010. PMID: 20541444

Similar articles

Tapentadol - A representative of a new class of MOR-NRI analgesics.
Zajączkowska R, Przewłocka B, Kocot-Kępska M, Mika J, Leppert W, Wordliczek J. Zajączkowska R, et al. Pharmacol Rep. 2018 Aug;70(4):812-820. doi: 10.1016/j.pharep.2018.01.005. Epub 2018 Jan 31. Pharmacol Rep. 2018. PMID: 29921501 Review.
Tapentadol hydrochloride: a next-generation, centrally acting analgesic with two mechanisms of action in a single molecule.
Tzschentke TM, Jahnel U, Kogel B, Christoph T, Englberger W, De Vry J, Schiene K, Okamoto A, Upmalis D, Weber H, Lange C, Stegmann JU, Kleinert R. Tzschentke TM, et al. Drugs Today (Barc). 2009 Jul;45(7):483-96. doi: 10.1358/dot.2009.45.7.1395291. Drugs Today (Barc). 2009. PMID: 19834626 Review.
Tapentadol: an initial analysis.
Prommer EE. Prommer EE. J Opioid Manag. 2010 May-Jun;6(3):223-6. doi: 10.5055/jom.2010.0020. J Opioid Manag. 2010. PMID: 20642251 Review.
Considering tapentadol as a first-line analgesic: 14 questions.
Pergolizzi JV Jr, Breve F, Taylor R Jr, Raffa RB, Strasburger SE, LeQuang JA. Pergolizzi JV Jr, et al. Pain Manag. 2017 Jul;7(4):331-339. doi: 10.2217/pmt-2016-0063. Epub 2017 Apr 24. Pain Manag. 2017. PMID: 28434283
Unique pharmacology of tapentadol for treating acute and chronic pain.
Knezevic NN, Tverdohleb T, Knezevic I, Candido KD. Knezevic NN, et al. Expert Opin Drug Metab Toxicol. 2015;11(9):1475-92. doi: 10.1517/17425255.2015.1072169. Epub 2015 Jul 29. Expert Opin Drug Metab Toxicol. 2015. PMID: 26215077

See all similar articles

Cited by

Multiple effectiveness aspects of tapentadol for moderate-severe cancer-pain treatment: an observational prospective study.
Cascella M, Forte CA, Bimonte S, Esposito G, Romano C, Costanzo R, Morabito A, Cuomo A. Cascella M, et al. J Pain Res. 2018 Dec 24;12:117-125. doi: 10.2147/JPR.S181079. eCollection 2019. J Pain Res. 2018. PMID: 30613160 Free PMC article.
Differences in the Analgesic Effect of Opioids on Pain in Cancer Patients With Spinal Metastases.
Takemura M, Niki K, Okamoto Y, Tamura H, Kawamura T, Kohno M, Matsuda Y, Ikeda K. Takemura M, et al. Palliat Med Rep. 2023 Aug 9;4(1):220-230. doi: 10.1089/pmr.2023.0018. eCollection 2023. Palliat Med Rep. 2023. PMID: 37637760 Free PMC article.
Tapentadol in the management of chronic low back pain: a novel approach to a complex condition?
Pergolizzi J, Alon E, Baron R, Bonezzi C, Dobrogowski J, Gálvez R, Jensen T, Kress HG, Marcus MA, Morlion B, Perrot S, Treede RD. Pergolizzi J, et al. J Pain Res. 2011;4:203-10. doi: 10.2147/JPR.S19625. Epub 2011 Jul 21. J Pain Res. 2011. PMID: 21887117 Free PMC article.
Multimechanistic Single-Entity Combinations for Chronic Pain Control: A Narrative Review.
Pergolizzi J, Magnusson P, Coluzzi F, Breve F, LeQuang JAK, Varrassi G. Pergolizzi J, et al. Cureus. 2022 Jun 16;14(6):e26000. doi: 10.7759/cureus.26000. eCollection 2022 Jun. Cureus. 2022. PMID: 35855248 Free PMC article. Review.
Patient considerations in the use of tapentadol for moderate to severe pain.
Vadivelu N, Huang Y, Mirante B, Jacoby M, Braveman FR, Hines RL, Sinatra R. Vadivelu N, et al. Drug Healthc Patient Saf. 2013 Jul 3;5:151-9. doi: 10.2147/DHPS.S28829. Print 2013. Drug Healthc Patient Saf. 2013. PMID: 23861601 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information